Hutchinson Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$437K Sell
475
-1
-0.2% -$1.01K 0.08% 67
2025
Q4
$512K Buy
476
+7
+1% +$6.69K 0.09% 65
2025
Q3
$358K Buy
469
+1
+0.2% +$744 0.06% 79
2025
Q2
$365K Hold
468
0.07% 74
2025
Q1
$387K Hold
468
0.07% 70
2024
Q4
$361K Sell
468
-9
-2% -$7.45K 0.07% 73
2024
Q3
$423K Sell
477
-3
-0.6% -$2.7K 0.08% 68
2024
Q2
$435K Buy
480
+9
+2% +$7.2K 0.09% 62
2024
Q1
$366K Buy
471
+3
+0.6% +$2.13K 0.07% 64
2023
Q4
$273K Sell
468
-3
-0.6% -$1.75K 0.06% 73
2023
Q3
$253K Sell
471
-102
-18% -$52.6K 0.06% 71
2023
Q2
$269K Buy
+573
New +$240K 0.06% 73
2023
Q1
Sell
-553
Closed -$202K 71
2022
Q4
$202K Buy
+553
New +$196K 0.05% 68
2022
Q3
Sell
-648
Closed -$210K 71
2022
Q2
$210K Buy
+648
New +$195K 0.05% 72

Other funds holding LLY

Hutchinson Capital Management's LLY Position: Q1 2026 in Review

Hutchinson Capital Management reduced its Eli Lilly (LLY) stake by 0.21% in Q1 2026, selling an estimated $1.01K and leaving 475 shares worth $437K. The position accounts for 0.08% of the portfolio, ranked #67.

Hutchinson Capital Management first reported a position in LLY in Q2 2022 and has held it in 14 quarters since. The position peaked at $512K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hutchinson Capital Management held 475 shares of Eli Lilly worth $437K as of Q1 2026.
  • Hutchinson Capital Management sold 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.08% of Hutchinson Capital Management's portfolio in Q1 2026, its #67 holding.
  • Hutchinson Capital Management first reported a position in Eli Lilly in Q2 2022 and has held it in 14 quarters since.
  • Hutchinson Capital Management's Eli Lilly position peaked at $512K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hutchinson Capital Management's 13F filing for Q1 2026, filed 12 May 2026.